Hepatic safety of repeated treatment with pyronaridine‐artesunate versus artemether–lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso

BACKGROUND: The use of pyronaridine-artesunate (PA) has been associated with scarce transaminitis in patients. This analysis aimed to evaluate the hepatic safety profile of repeated treatment with PA versus artemether–lumefantrine (AL) in patients with consecutive uncomplicated malaria episodes in B...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Malar J
Main Authors: Compaoré, Yves Daniel, Zongo, Issaka, Somé, Anyirékun F., Barry, Nouhoun, Nikiéma, Frederick, Kaboré, Talato N., Ouattara, Aminata, Kabré, Zachari, Wermi, Kadidiatou, Zongo, Moussa, Yerbanga, Rakiswende S., Sagara, Issaka, Djimdé, Abdoulaye, Ouédraogo, Jean Bosco
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7847156/
https://ncbi.nlm.nih.gov/pubmed/33514368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-021-03593-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados